Sunday 12 May, 2024 03:49 PM
Site map | Locate Us | Login
   Thermax Q4 PAT rises 22% YoY to Rs 190 cr    Piramal Pharma Q4 PAT doubles to Rs 101 crore    Union Bank of India Q4 PAT grows 19% YoY to Rs 3,310 cr    Bank of India Q4 PAT rises 6% YoY; board OKs raising Rs 5,000 crore    ABB India Q1 PAT soars 87% to Rs 460 cr    Eicher Motors Q4 PAT climbs 18% YoY to Rs 1,070 cr    Tata Motors Q4 PAT soars to Rs 17,529 crore    Bank of Baroda PAT rises to Rs 4,886 cr in Q4 FY24    Cipla rises Q4 PAT climbs 79% YoY to Rs 939 cr; declares dividend of Rs 13/share    Dr. Lal PathLabs spurts as Q4 PAT climbs 49% YoY to Rs 84 cr    Intellect Design Arena Ltd leads losers in 'A' group    Rushil Decor Ltd leads losers in 'B' group    Volumes jump at Vijaya Diagnostic Centre Ltd counter    Information Technology shares fall    Real Estate stocks edge lower 
Saravan Stocks
       
Company News
Aurobindo Pharma Ltd
Auro Pharma’s Andhra Pradesh facility gets 3 USFDA observations
Apr 08,2024   Hrs IST

The new injectable facility of Eugia Steriles (a 100% subsidiary of Eugia Pharma Specialities and a stepdown subsidiary of the company), situated at Parawada Mandal, Anakapalli district, Andhra Pradesh, has recently started the commercial operations.

The United States Food and Drug Administration (USFDA) inspected the facility from 28 March 2024 to 5 April 2024.

The inspection closed with three observations. The observations are procedural in nature and will be responded to within the stipulated time, the company stated in the press release.

On 6 April 2024, the company informed that an accident occurred near Vacuum Tray Dryer (VTD) area at Unit 6 of Apitoria Pharma (wholly owned subsidiary of the company), situated at Parawada, Anakapalli district, Andhra Pradesh. The firm said that there was one casualty due to the accident.

Further, the company added the unit continues its normal operations.

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.

The drug maker reported 90.58% jump in consolidated net profit to Rs 936.29 crore on 13.82% rise in revenue from operations to Rs 7,271.23 crore in Q3 FY24 over Q3 FY23.

The scrip shed 0.19% to end at Rs 1,121 on the BSE.

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Span Margin | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures |Rights & Obligations-English| Rights & Obligations-தமிழ் | Anti Money Laundering Policy | E-Voting | CSR Hit Count : 32546416
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd